178 related articles for article (PubMed ID: 12388551)
21. Generation of the membrane attack complex during haemodialysis: impact of classical and alternative pathway components.
Hauser AC; Derfler K; Stockenhuber F; Janata O; Balcke P
Clin Sci (Lond); 1990 Nov; 79(5):471-6. PubMed ID: 2174314
[TBL] [Abstract][Full Text] [Related]
22. Activation of the classical complement pathway in brain tissue of Alzheimer patients.
McGeer PL; Akiyama H; Itagaki S; McGeer EG
Neurosci Lett; 1989 Dec; 107(1-3):341-6. PubMed ID: 2559373
[TBL] [Abstract][Full Text] [Related]
23. Modeling familial Danish dementia in mice supports the concept of the amyloid hypothesis of Alzheimer's disease.
Coomaraswamy J; Kilger E; Wölfing H; Schäfer C; Kaeser SA; Wegenast-Braun BM; Hefendehl JK; Wolburg H; Mazzella M; Ghiso J; Goedert M; Akiyama H; Garcia-Sierra F; Wolfer DP; Mathews PM; Jucker M
Proc Natl Acad Sci U S A; 2010 Apr; 107(17):7969-74. PubMed ID: 20385796
[TBL] [Abstract][Full Text] [Related]
24. Non-fibrillar oligomeric species of the amyloid ABri peptide, implicated in familial British dementia, are more potent at inducing apoptotic cell death than protofibrils or mature fibrils.
El-Agnaf OM; Nagala S; Patel BP; Austen BM
J Mol Biol; 2001 Jun; 310(1):157-68. PubMed ID: 11419943
[TBL] [Abstract][Full Text] [Related]
25. Role of BRI2 in dementia.
Del Campo M; Teunissen CE
J Alzheimers Dis; 2014; 40(3):481-94. PubMed ID: 24473189
[TBL] [Abstract][Full Text] [Related]
26. Cerebral amyloid angiopathy and parenchymal amyloid deposition in transgenic mice expressing the Danish mutant form of human BRI2.
Vidal R; Barbeito AG; Miravalle L; Ghetti B
Brain Pathol; 2009 Jan; 19(1):58-68. PubMed ID: 18410407
[TBL] [Abstract][Full Text] [Related]
27. Amyloidogenesis in familial British dementia is associated with a genetic defect on chromosome 13.
Ghiso J; Vidal R; Rostagno A; Miravalle L; Holton JL; Mead S; Révész T; Plant G; Frangione B
Ann N Y Acad Sci; 2000; 920():84-92. PubMed ID: 11193180
[TBL] [Abstract][Full Text] [Related]
28. The familial dementia BRI2 gene binds the Alzheimer gene amyloid-beta precursor protein and inhibits amyloid-beta production.
Matsuda S; Giliberto L; Matsuda Y; Davies P; McGowan E; Pickford F; Ghiso J; Frangione B; D'Adamio L
J Biol Chem; 2005 Aug; 280(32):28912-6. PubMed ID: 15983050
[TBL] [Abstract][Full Text] [Related]
29. Molecular chaperons, amyloid and preamyloid lesions in the BRI2 gene-related dementias: a morphological study.
Lashley T; Holton JL; Verbeek MM; Rostagno A; Bojsen-Møller M; David G; van Horssen J; Braendgaard H; Plant G; Frangione B; Ghiso J; Revesz T
Neuropathol Appl Neurobiol; 2006 Oct; 32(5):492-504. PubMed ID: 16972883
[TBL] [Abstract][Full Text] [Related]
30. Properties of neurotoxic peptides related to the Bri gene.
El-Agnaf O; Gibson G; Lee M; Wright A; Austen BM
Protein Pept Lett; 2004 Jun; 11(3):207-12. PubMed ID: 15182222
[TBL] [Abstract][Full Text] [Related]
31. Oligomerization and neurotoxicity of the amyloid ADan peptide implicated in familial Danish dementia.
Gibson G; Gunasekera N; Lee M; Lelyveld V; El-Agnaf OM; Wright A; Austen B
J Neurochem; 2004 Jan; 88(2):281-90. PubMed ID: 14690516
[TBL] [Abstract][Full Text] [Related]
32. Synovial fluid levels of complement SC5b-9 and fragment Bb are elevated in patients with rheumatoid arthritis.
Brodeur JP; Ruddy S; Schwartz LB; Moxley G
Arthritis Rheum; 1991 Dec; 34(12):1531-7. PubMed ID: 1747138
[TBL] [Abstract][Full Text] [Related]
33. Structure and neurotoxicity of novel amyloids derived from the BRI gene.
Gibson G; El-Agnaf OM; Anwar Z; Sidera C; Isbister A; Austen BM
Biochem Soc Trans; 2005 Nov; 33(Pt 5):1111-2. PubMed ID: 16246057
[TBL] [Abstract][Full Text] [Related]
34. Lessons from a Rare Familial Dementia: Amyloid and Beyond.
Cantlon A; Frigerio CS; Walsh DM
J Parkinsons Dis Alzheimers Dis; 2015 Aug; 2(1):. PubMed ID: 26405694
[TBL] [Abstract][Full Text] [Related]
35. Alzheimer's and Danish dementia peptides induce cataract and perturb retinal architecture in rats.
Reddy GB; Reddy PY; Surolia A
Biomol Concepts; 2017 Mar; 8(1):45-84. PubMed ID: 28222009
[TBL] [Abstract][Full Text] [Related]
36. Systemic amyloid deposits in familial British dementia.
Ghiso JA; Holton J; Miravalle L; Calero M; Lashley T; Vidal R; Houlden H; Wood N; Neubert TA; Rostagno A; Plant G; Revesz T; Frangione B
J Biol Chem; 2001 Nov; 276(47):43909-14. PubMed ID: 11557758
[TBL] [Abstract][Full Text] [Related]
37. Inhibiting the formation of classical C3-convertase on the Alzheimer's beta-amyloid peptide.
Emmerling MR; Spiegel K; Watson MD
Immunopharmacology; 1997 Dec; 38(1-2):101-9. PubMed ID: 9476121
[TBL] [Abstract][Full Text] [Related]
38. Amyloid and intracellular accumulation of BRI
Garringer HJ; Sammeta N; Oblak A; Ghetti B; Vidal R
Neurobiol Aging; 2017 Apr; 52():90-97. PubMed ID: 28131015
[TBL] [Abstract][Full Text] [Related]
39. A newly formed amyloidogenic fragment due to a stop codon mutation causes familial British dementia.
Ghiso J; Vidal R; Rostagno A; Mead S; Révész T; Plant G; Frangione B
Ann N Y Acad Sci; 2000 Apr; 903():129-37. PubMed ID: 10818498
[TBL] [Abstract][Full Text] [Related]
40. Memory deficits due to familial British dementia BRI2 mutation are caused by loss of BRI2 function rather than amyloidosis.
Tamayev R; Giliberto L; Li W; d'Abramo C; Arancio O; Vidal R; D'Adamio L
J Neurosci; 2010 Nov; 30(44):14915-24. PubMed ID: 21048150
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
